Navigation Links
Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
Date:7/20/2009

London, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related credit crunch has had an impact, this alone cannot account for the recent M&A mania, which has including four mega M&As in the first half of 2009.

(Logo:http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"The real intention behind these mergers remains a question, as past mergers have not yielded substantial value addition in terms of R&D productivity," says Frost & Sullivan Senior Research Analyst Ranjith Gopinathan.

To look at these Mergers & Acquisitions in the Pharmaceutical and Biotechnology industry, the Healthcare Group at Frost & Sullivan will be hosting a complimentary Analyst Briefing Presentation on Tuesday, 28th July 2009, at 2 p.m. BST/ 1 p.m. GMT.

Highlights of this briefing will include an analysis of the factors contributing to the increasing consolidation in the market, the impact of the economic downturn, as well as funding sources for biotech companies. The briefing will also look at key restraints for M&A activities in the pharma-biotech industry and provide a future M&A outlook. The discussion will benefit venture capitalists, investment banks, pharma and biotech companies as well as academic institutions.

"The global downturn's detrimental impact on funding availability coupled with an average 30 per cent decline in the value of biotech firms, means that outright acquisitions rather than complex licensing deals are an attractive proposition," concludes Gopinathan.

To participate in this briefing, please email Patrick Cairns at

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
2. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
3. Pharmacyclics Announces Subscription Price for Rights Offering
4. EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimers Disease
5. Simcere Pharmaceutical Group Notice of Annual General Meeting
6. Amylin Pharmaceuticals to Webcast Second Quarter Results
7. EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimers Disease Transgenic Mouse Model With Gamma-Secretase Modulator
8. Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
9. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
10. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
11. ParagonRx Creates New Website Featuring REMS Help Center for Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three ... second quarter financial statements and MD&A have been filed on SEDAR ( ... Six-months ended June 30, ( in CDN$,000 except per share ... 2014 , 2013 Revenue , 2,459 , ... 56 , 1,485 , 385 , ...
(Date:8/22/2014)... University of Surrey have discovered how the receptors responsible ... genes. , The new study, published today in ... activity in turn regulates the cycle of all cells ... that the local biological clock and its control are ... clock in bladder physiology and ageing. , ...
(Date:8/22/2014)... (August 22nd), in the scientific journal PLoS ... establish the effect of serotonin on sensitivity to ... optical techniques., "Serotonin is a small molecule known ... brain functions, from the control of sleep and ... This neurotransmitter is also popularly thought to contribute ...
(Date:8/22/2014)... The first direct observations of how facets form ... towards more sophisticated and effective nanocrystal design and ... describing crystal growth breaks down at the nanoscale. ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) used ... high-resolution, fast-detection camera to capture the physical ...
Breaking Biology Technology:Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2From happiness to pain: Understanding serotonin's function 2Shaping the future of nanocrystals 2Shaping the future of nanocrystals 3Shaping the future of nanocrystals 4
... an award-winning remote-detection version of NMR/MRI technology with ... microfluidic chips, researchers with the U.S. Department of ... have opened the door to a portable system ... be impractical if not impossible with conventional technologies. ...
... Around the globe, many nations are realizing that the ... say. And because an intentional introduction of bacteria, ... World Organization for Animal Health is issuing a paper ... beginning to think about maintaining international trade needs to ...
... of careful theoretical modeling and precise micro-manufacturing, a team ... of ultra-thin, self-adhesive electronics device that can effectively measure ... activity all without the use of bulky equipment, ... a new class of micro-electronics with a technology that ...
Cached Biology Technology:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 2Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 3Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 4Global bioterrorism threat analyzed for world animal health office 2Stick-on tattoos go electric 2Stick-on tattoos go electric 3
(Date:8/22/2014)... Calif. Thomson Reuters , a leading source ... researchers at the University of California, Riverside in its ... minds of our times." , To generate the list, ... to identify researchers whose published work has had enormous ... among some 3,200 individuals who published the greatest number ...
(Date:8/22/2014)... Research presented at the 29th Annual International ... by Hera Therapeutics Inc. combats three types of ... percent of all cervical cancer. , When tested ... the replication of HPV-16, HPV-18 and HPV-11 cells, ... Broker, Ph.D., who presented the findings at the ...
(Date:8/22/2014)... is available in French . ... essential nutrients from African soils looming as a major threat ... today finds that over the last five years, 1.7 million ... have rejuvenated 1.6 million hectares and helped them double or ... for a Green Revolution in Africa (AGRA) focuses on intensive ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 3Effort to confront Africa's soil health crisis helps millions of farmers triple yields 4
... mammalian embryo is one of the most contentious topics ... Hiiragi have new evidence to fuel the ongoing debate. ... showed compelling evidence for the absence of predetermined polarity ... contrast to those who feel that the site of ...
... novel retroviral resistance gene, called FEZ1, that can mediate a ... in cell culture. The researchers found that the high level ... caused a significant block to retroviral infection ?retroviruses were able ... but were excluded from entering the host cell nucleus. , ...
... drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, ... enzymes involved in cellular metabolism, according to a team ... of biochemistry and molecular biology at the Keck School ... The cellular disruption results in increases in the amount ...
Cached Biology News:USC researchers determine mechanism of action of chemotherapy drug 2